文献速递肿瘤 PET/CT

胰胆管癌[68Ga]Ga-FAPI-46 PET/CT半定量测量的可重复性:一项重测研究

Repeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers: a test-retest study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-01-16

结果显示SUVmean、SUVpeak、SUVmax的重复性系数分别为23.7%、23.9%、29.8%,所有ICC均高于0.98,表明半定量测量具有极好的可重复性,有望用于未来疗效评估研究。

要点

  • SUVmean、SUVpeak、SUVmax的重复性系数分别为23.7%、23.9%、29.8%。
  • 所有半定量指标的ICC均高于0.98,提示极好的重测可重复性。

核心结论

  • [68Ga]Ga-FAPI-46 PET/CT半定量测量在胰胆管癌中具有极好的可重复性,可能可用于未来疗效评估研究。

研究设计与样本

  • 纳入病理确诊的胰胆管癌患者(PDAC或CCA),在7天内无治疗前后行两次[68Ga]Ga-FAPI-46 PET/CT。
  • 注射后60分钟行静态长轴视野(LAFOV)PET/CT(EARL2兼容重建),对可疑恶性病灶半自动勾画(局部本底校正的SUV峰值50%等值线)并提取SUVmean、SUVpeak、SUVmax及TBR。
  • 采用重复性系数(RC)和组内相关系数(ICC)评估可重复性。

主要发现

  • 共勾画70个FAPI阳性病灶。
  • SUVmean、SUVpeak、SUVmax的RC分别为23.7%、23.9%、29.8%。
  • 血池校正TBRmean、TBRpeak、TBRmax的RC分别为21.6%、20.8%、28.0%。
  • 所有ICC均高于0.98。

关键数值与推荐

  • 重复性系数(RC):SUVmean 23.7%,SUVpeak 23.9%,SUVmax 29.8%。
  • 血池校正TBR的RC:TBRmean 21.6%,TBRpeak 20.8%,TBRmax 28.0%。
  • 所有半定量指标的ICC均高于0.98。

临床怎么用

  • 在胰胆管癌中,[68Ga]Ga-FAPI-46 PET/CT的SUV和TBR半定量测量具有极好的重测可重复性,支持将其用于未来疗效评估研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiolabelled fibroblast activation protein inhibitors (FAPI) are promising molecular imaging tracers for the diagnosis and staging of pancreatobiliary cancer. To enable treatment response assessment with [68Ga]Ga-FAPI-46, the day-to-day variability of its uptake must be defined. This study aimed to determine the repeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers. METHODS: Patients with pathologically confirmed pancreatobiliary cancer (pancreatic ductal adenocarcinoma (PDAC) or cholangiocarcinoma (CCA)) were included. Patients underwent two [68Ga]Ga-FAPI-46 PET/CT scans, within 7 days, without any treatment before or between scans. Static long axial field-of-view (LAFOV) PET/CT scans were performed 60 min post-injection of [68Ga]Ga-FAPI-46 (EARL2-compliant reconstruction). Suspected malignant lesions were semi-automatically delineated (local background-adjusted 50% isocontour of the peak standardised uptake value (SUV)) and semi-quantitative measurements were extracted (SUVmean, SUVpeak and SUVmax). Tumour-to-background ratios (TBR) were also calculated. Repeatability was assessed using the repeatability coefficient (RC) and the intraclass correlation coefficient (ICC). RESULTS: Twelve patients were included (seven PDAC, three perihilar CCA and two intrahepatic CCA). The median injected dose was 216 MBq (interquartile range (IQR) 167-266 MBq) and the median uptake time was 60 min (range 60-68). In total, 70 FAPI-positive lesions were delineated. The RCs of SUVmean, SUVpeak and SUVmax were 23.7%, 23.9% and 29.8%, respectively. For the blood pool adjusted TBRmean, TBRpeak and TBRmax, the RC's were 21.6%, 20.8% and 28.0%, respectively. All ICCs were above 0.98. CONCLUSION: Semi-quantitative measurements of [68Ga]Ga-FAPI-46 PET/CT have an excellent repeatability and can potentially be used in future studies to assess treatment response in pancreatobiliary cancers.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Henrar RB, Cysouw MCF, Palard-Novello X, et al. Repeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers: a test-retest study. Eur J Nucl Med Mol Imaging. 2026. PMID: 41540241. doi:10.1007/s00259-025-07738-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。